• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, July 27, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Chemistry

Using fungi to search for medical drugs

Bioengineer by Bioengineer
November 26, 2019
in Chemistry
Reading Time: 4 mins read
0
ADVERTISEMENT
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Jelmer Hoeksma, © Hubrecht Institute

An enormous library of products derived from more than ten thousand fungi could help us find new drugs. Researchers from the group of Jeroen den Hertog at the Hubrecht Institute, in collaboration with researchers from the Westerdijk Institute and Utrecht University, have set up this library and screened it for biologically active compounds. They tested the biological activity of these fungal products first using zebrafish embryos. The researchers chose to use zebrafish embryos, because it allows the analysis of effects on many cell types at the same time, in a working body, and because zebrafish are physiologically very similar to humans. They have already found various known compounds, among which the cholesterol lowering drug lovastatin. The library of fungal products offers ample opportunity to search for new drugs. The results of this research were published on the 26th of November in the scientific journal Scientific Reports.

Fungal products

We constantly need new therapeutic compounds in the clinic for various reasons, including our increasing age, with corresponding illnesses, and resistance to existing drugs. Fungi are an excellent, but underexplored source of these kinds of compounds, such as lovastatin, a compound produced by the fungus Aspergillus terreus and that is used as a cholesterol lowering drug. Jelmer Hoeksma, one of the researchers at the Hubrecht Institute, explains: “Every year new compounds produced by fungi are identified, but so far we have only investigated a very small subset of all existing fungi. This suggests that many more biologically active compounds remain to be discovered.”

Ten thousand fungi

The collaboration with the Westerdijk Fungal Biodiversity Institute, home to the largest collection of live fungi in the world, enabled the researchers to set up a large library of filtrates derived from more than ten thousand different fungi. A filtrate contains all the products that the fungus excretes. To search for therapeutic compounds, the researchers investigated the effects of this large library of fungal products first on zebrafish embryos. The zebrafish embryos enabled the researchers to study effects on the whole body during development. Zebrafish are vertebrates that are physiologically very similar to humans and are often used to test drugs for a variety of disorders. Within a few days these embryos develop most of their organs, making biological activity of the fungal compounds readily detectable. In addition, comparison to known drugs may result in identification of new drugs and also point towards the underlying mechanisms of action of these compounds.

Pigmentation

The researchers found 1526 filtrates that contain biologically active compounds with an effect on zebrafish embryos, from which they selected 150 filtrates for further analysis. From these, they isolated 34 known compounds, including the cholesterol lowering drug lovastatin, which was produced by the fungus Resinicium furfuraceum. Until now it was unknown that this fungus produces lovastatin. In addition, the researchers found filtrates that affect pigmentation in zebrafish embryos. Other studies have shown that factors involved in pigmentation can also play a crucial role in the development of skin cancer. The researchers are currently isolating the active compounds that cause pigmentation defects in zebrafish embryos from the filtrates.

Tip of the iceberg

This study underlines the large variety of biologically active compounds that are produced by fungi and the importance of further investigating these compounds in the search for new drugs. Hoeksma: “The large library of fungal filtrates that we have set up can also be tested in many other systems, such as models for antibiotic resistance in bacteria and tumor development, making this study only the tip of the iceberg.”

###

Publication

A new perspective on fungal metabolites: identification of bioactive compounds from fungi using zebrafish embryogenesis as read-out. Jelmer Hoeksma, Tim Misset, Christie Wever, Johan Kemmink, John Kruijtzer, Kees Versluis, Rob M.J. Liskamp, Geert Jan Boons, Albert J.R. Heck, Teun Boekhout en Jeroen den Hertog. Scientific Reports 2019.

This research combines expertise in the fields of developmental biology, fungal cultures and chemistry in a collaboration between the Hubrecht Institute for Developmental Biology and Stem Cell Research, the Westerdijk Fungal Biodiversity Institute and Utrecht University.

Jeroen den Hertog is group leader at the Hubrecht Institute in Utrecht and professor of Molecular Developmental Zoology at Leiden University.

Teun Boekhout is group leader at the Westerdijk Institute in Utrecht and professor of Fungal Functional Diversity at the University of Amsterdam.

About the Hubrecht Institute

The Hubrecht Institute is a research institute focused on developmental and stem cell biology. It encompasses 23 research groups that perform fundamental and multidisciplinary research, both in healthy systems and disease models. The Hubrecht Institute is a research institute of the Royal Netherlands Academy of Arts and Sciences (KNAW), situated on Utrecht Science Park. Since 2008, the institute is affiliated with the UMC Utrecht, advancing the translation of research to the clinic. The Hubrecht Institute has a partnership with the European Molecular Biology Laboratory (EMBL). For more information, visit http://www.hubrecht.eu.

About the Westerdijk Fungal Biodiversity Institute

The Westerdijk Fungal Biodiversity Institute is the largest expertise centre for microfungi in the world. Our renowned researchers dedicate themselves to enriching and expanding our Fungal Biobank. We explore the fungal kingdom to gain a better understanding of their fungal characteristics and their potential applications, especially in the fields of industry, agriculture and healthcare.

The Westerdijk Fungal Biodiversity Institute is part of the Royal Netherlands Academy of Arts and Sciences (KNAW). For more information, go to http://www.westerdijkinstitute.nl. Explore – study – preserve.
” target=”_blank”>KNAW). For more information, go to http://www.westerdijkinstitute.nl. Explore – study – preserve.

Media Contact
Melanie Fremery
[email protected]
31-683-596-548

Related Journal Article

http://dx.doi.org/10.1038/s41598-019-54127-9

Tags: Developmental/Reproductive BiologyMedicine/HealthMycologyPharmaceutical/Combinatorial ChemistryZoology/Veterinary Science
Share12Tweet8Share2ShareShareShare2

Related Posts

Architecture of VBayesMM

Unraveling Gut Bacteria Mysteries Through AI

July 4, 2025
Visulaization of ATLAS collision

Can the Large Hadron Collider Prove String Theory Right?

July 3, 2025

Breakthrough in Gene Therapy: Synthetic DNA Nanoparticles Pave the Way

July 3, 2025

Real-Time Electrochemical Microfluidic Monitoring of Additive Levels in Acidic Copper Plating Solutions for Metal Interconnections

July 3, 2025
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    51 shares
    Share 20 Tweet 13
  • USF Research Unveils AI Technology for Detecting Early PTSD Indicators in Youth Through Facial Analysis

    42 shares
    Share 17 Tweet 11
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    45 shares
    Share 18 Tweet 11
  • New Measurements Elevate Hubble Tension to a Critical Crisis

    43 shares
    Share 17 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Advanced Pressure-Velocity Patch Enhances Flight Detection

Durable, Flexible Electrochemical Transistors via Electropolymerized PEDOT

Challenges and Opportunities in High-Filled Polymer Manufacturing

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.